Teva Pharmaceutical Industries Limited (TEVA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Teva Pharmaceutical Indus...

    NYSE: TEVA · Real-Time Price · USD
    18.34
    -0.02 (-0.08%)
    At close: Sep 26, 2025, 3:59 PM
    18.39
    0.27%
    After-hours: Sep 26, 2025, 07:54 PM EDT

    Teva Pharmaceutical Industries Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.3B 3.23B 2.8B 2.17B
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a 8M n/a n/a
    Other Long-Term Assets
    		 462M 463M 441M 515M
    Receivables
    		 3.06B 3.41B 3.7B 4.53B
    Inventory
    		 3.01B 4.02B 3.83B 3.82B
    Other Current Assets
    		 2.18B 575M 559M 986M
    Total Current Assets
    		 12.55B 12.48B 12.05B 12.57B
    Property-Plant & Equipment
    		 4.95B 6.15B 6.16B 6.48B
    Goodwill & Intangibles
    		 19.57B 22.56B 23.9B 27.51B
    Total Long-Term Assets
    		 26.77B 30.99B 31.95B 35.09B
    Total Assets
    		 39.33B 43.48B 44.01B 47.67B
    Account Payables
    		 2.2B 2.6B 1.89B 1.69B
    Deferred Revenue
    		 n/a n/a 1.45B 7.01B
    Short-Term Debt
    		 1.78B 1.67B 2.11B 1.43B
    Other Current Liabilities
    		 6.02B 5.11B 972M 231M
    Total Current Liabilities
    		 12.8B 12.25B 11.47B 11.03B
    Long-Term Debt
    		 16B 18.16B 19.1B 21.62B
    Other Long-Term Liabilities
    		 4.03B 4.02B 3.94B 2.58B
    Total Long-Term Liabilities
    		 20.81B 23.11B 23.85B 25.39B
    Total Liabilities
    		 33.61B 35.35B 35.31B 36.42B
    Total Debt
    		 18.08B 20.15B 21.56B 23.46B
    Book Value
    		 5.72B 8.13B 8.69B 11.24B
    Book Value Per Share
    		 5.06 7.26 7.83 10.20
    Common Stock
    		 58M 57M 57M 57M
    Retained Earnings
    		 -15.17B -13.53B -12.88B -10.53B
    Comprehensive Income
    		 -3.15B -2.7B -2.84B -2.68B
    Shareholders Equity
    		 5.38B 7.51B 7.9B 10.28B
    Total Investments
    		 n/a 8M n/a n/a

    Add to Watchlist